Item 2.02 - Results of Operations and Financial Condition: The filing reports GE HealthCare Technologies Inc.'s financial results and operational performance as of February 4, 2026 Item 9.01 - Financial Statements and Exhibits: The filing includes financial statements and exhibits related to the reported results Company Information: GE HealthCare Technologies Inc. is incorporated in Delaware,…

Our analysis rates this filing CAUTIOUS. GE HealthCare Technologies presents an elevated but manageable concern profile. The primary driver is newly quantified tariff expense impact materially compressing margins (200-320 bps) in Q4 2025, with net income declining 18% YoY despite revenue growth—a…

Concern level: ELEVATED (5.8/10). Key factors: Material tariff expense impact: 200 bps Adjusted EBIT margin compression and $0.28 EPS decline YoY in Q4 2025 - newly quantified headwind representing significant profitability pressure; Net income margin compression of 320 bps (13.5% to 10.3%) despite revenue growth, indicating earnings growth significantly lagging revenue growth - classic margin…

Notable risk changes: Tariff expenses emerged as material margin headwind in Q4 2025, reducing Adjusted EBIT margin by 200 bps and diluted EPS by $0.28 YoY. This represents a newly quantified negative impact on profitability not previously disclosed.; Unfavorable product mix cited alongside tariffs as margin pressure factor, suggesting potential shift toward lower-margin business or competitive pricing dynamics that…

The model predicts GEHC will underperform the S&P 500 by about 0.0% over 30 days. This is model analysis for research, not investment advice.